PLAU and ovarian cancer: LPA has been shown to induce shedding of the 80 kDa extracellular domain of E-cadherin in ovarian cancer cells in a urokinase plasminogen activator (uPA)-dependent manner, disrupting cell-cell junctions and promoting EMT with enhanced motility and invasion [203].